Collectins and ficolins: Humoral lectins of the innate immune defense

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 547-578

  Holmskov, Uffe ^a   Thiel, Steffen ^b   Jensenius, Jens C ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Complement; Infections; Innate immunity; Surfactant

Indexed keywords

ACUTE PHASE PROTEIN; COLLECTIN; FICOLIN; LIPOTEICHOIC ACID; LUNG SURFACTANT; MANNAN BINDING LECTIN; PLASMA PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; CARRIER PROTEIN; IMMUNOGLOBULIN RECEPTOR; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; SERINE PROTEINASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ALPHA HELIX; AMNION FLUID; ANTIBODY DEPENDENT ENHANCEMENT; ASPERGILLUS FUMIGATUS; BACTERIAL CELL WALL; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBOHYDRATE ANALYSIS; CELL DIFFERENTIATION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; DENDRITIC CELL; DOWN REGULATION; HAEMOPHILUS INFLUENZAE TYPE A; HERPES SIMPLEX VIRUS; HORMONAL REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; INFLUENZA VIRUS; LECTIN BINDING SITE; LUNG ALVEOLUS CELL TYPE 2; LUNG INFILTRATE; NEISSERIA MENINGITIDIS; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SALMONELLA TYPHIMURIUM; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; FUNGUS; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; PHYLOGENY; VIRUS;

ANIMALS; BACTERIA; CARRIER PROTEINS; COLLECTINS; COMPLEMENT ACTIVATION; FUNGI; HUMANS; IMMUNITY, NATURAL; LECTINS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MICE; MODELS, MOLECULAR; PHYLOGENY; POLYMORPHISM, GENETIC; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; SERINE ENDOPEPTIDASES; VIRUSES;

EID: 0041534400     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.140954     Document Type: Review

References (180)

1. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
2. Hallman M, Ramet M, Ezekowitz RA. 2001. Toll-like receptors as sensors of pathogens. Pediatr. Res. 50:315-21
3. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-95
4. Bordet J, Streng O. 1906. Les phénomènes d'absorption de la conglutinin du serum de boeuf. Ann. Inst. Pasteur 49:260-76
5. Leon MA, Yokohari R. 1964. Conglutination: specific inhibition by carbohydrates. Science 143:1327-28
6. Holmskov U, Malhotra R, Sim RB, Jensenius JC. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74
7. Kawasaki T, Etoh R, Yamashina I. 1978. Isolation and characterization of mannan-binding protein from rabbit liver. Biochem. Biophys. Res. Commun. 81:1018-24
8. White RT, Damm D, Miller J, Spratt K, Schilling J, et al. 1985. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature 317:361-63
9. Persson A, Rust K, Chang D, Moxley M, Longmore W, Crouch E. 1988. CP4: a pneumocyte-derived collagenous suffactant-associated protein. Evidence for heterogeneity of collagenous suffactant proteins. Biochemistry 27:8576-84
10. Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, et al. 1999. Molecular cloning of a novel human collectin from liver (CL-L1). J. Biol. Chem. 274:13681-89
11. Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, et al. 2001. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276:44222-28
12. Hansen S, Holmskov U. 2003. Functional aspects of SP-D and the derived bovine collectins: conglutinin, CL-43 and CL-46. Immunobiology 205:In press
13. Ichijo H, Hellman U, Wemstedt C, Gonez LJ, Claesson-Welsh L, et al. 1993. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. J. Biol. Chem. 268:14505-13
14. Le Y, Tan SM, Lee SH, Kon OL, Lu J. 1997. Purification and binding properties of a human ficolin-like protein. J. Immunol. Methods 204:43-49
15. Matsushita M, Fujita T. 2001. Ficolins and the lectin complement pathway. Immunol. Rev. 180:78-85
16. Klein J. 1982. Immunology, The Science of Self-Nonself Discrimination, p. 315. New York: Wiley
17. Fujita T. 2002. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2:346-53
18. Gadjeva M, Thiel S, Jensenius JC. 2001. The mannan-binding-lectin pathway of the innate immune response. Curr. Opin. Immunol. 13:74-78
19. Jack DL, Klein NJ, Turner MW. 2001. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol. Rev. 180:86-99
20. Holmskov UL. 2000. Collectins and collectin receptors in innate immunity. APMIS 108(Suppl. 100):7-59
21. Crouch E, Wright JR. 2001. Suffactant proteins A and D and pulmonary host defense. Annu. Rev. Physiol. 63:521-54
22. McCormack FX, Whitsett JA, 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest. 109:707-12
23. Drickamer K. 1988. Two distinct classes of carbohydrate-recognition domains in animal lectins. J. Biol. Chem. 263:9557-60
24. Sheriff S, Chang CY, Ezekowitz RA. 1994. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat. Struct. Biol. 1:789-94
25. Weis WI, Drickamer K, Hendrickson WA. 1992. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360:127-34
26. Kairies N, Beisel HG, Fuentes-Prior P, Tsuda R, Muta T, et al. 2001. The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc. Natl. Acad. Sci. USA 98:13519-24
27. Hakansson K, Lim NK, Hoppe HJ, Reid KB. 1999. Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Struct. Fold. Des. 7:255-64
28. Drickamer K. 1992. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 360:183-86
29. Kawasaki N, Kawasaki T, Yamashina I. 1983. Isolation and characterization of a mannan-binding protein from human serum. J. Biochem. 94:937-47
30. Hansen S, Thiel S, Willis A, Holmskov U, Jensenius JC. 2000. Purification and characterization of two mannan-binding lectins from mouse serum. J. Immunol. 164:2610-18
31. Vitved L, Holmskov U, Koch C, Teisner B, Hansen S, Skjodt K. 2000. The homologue of mannose-binding lectin in the carp family Cyprinidae is expressed at high level in spleen, and the deduced primary structure predicts affinity for galactose. Immunogenetics 51:955-64
32. Lu J, Le Y. 1998. Ficolins and the fibrinogen-like domain. Immunobiology 199:190-99
33. Le Y, Lee SH, Kon OL, Lu J. 1998. Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett. 425:367-70
34. Matsushita M, Endo Y, Taira S, Sato Y, Fujita T, et al. 1996. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J. Biol. Chem. 271:2448-54
35. Sugimoto R, Yae Y, Akaiwa M, Kitajima S, Shibata Y, et al. 1998. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 273:20721-27
36. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. 2002. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168:3502-6
37. Tsujimura M, Ishida C, Sagara Y, Miyazaki T, Murakami K, et al. 2001. Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans. Clin. Diagn. Lab. Immunol. 8:454-59
38. Crouch E, Persson A, Chang D, Heuser J. 1994. Molecular structure of pulmonary surfactant protein D (SP-D). J. Biol. Chem. 269:17311-19
39. Holmskov U, Laursen SB, Malhotra R, Wiedemann H, Timpl R, et al. 1995. Comparative study of the structural and functional properties of a bovine plasma C-type lectin, collectin-43, with other collectins. Biochem. J. 305:889-96
40. Voss T, Eistetter H, Schafer KP, Engel J. 1988. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J. Mol. Biol. 201:219-27
41. Ohashi T, Erickson HP. 1997. Two oligomeric forms of plasma ficolin have differential lectin activity. J. Biol. Chem. 272:14220-26
42. Matsushita M, Fujita T. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1497-502
43. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-10
44. Dahl MR, Thiel S, Matsushita M, Fujita T, Willis AC, et al. 2001. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15:127-35
45. Stover CM, Thiel S, Thelen M, Lynch NJ, Vorup-Jensen T, et al. 1999. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 162:3481-90
46. Matsushita M, Endo Y, Fujita T. 2000. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164:2281-84
47. Chen CB, Wallis R. 2001. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation. J. Biol. Chem. 276:25894-902
48. Thielens NM, Cseh S, Thiel S, Vorup-Jensen T, Rossi V, et al. 2001. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J. Immunol. 166:5068-77
49. Thiel S, Petersen SV, Vorup-Jensen T, Matsushita M, Fujita T, et al. 2000. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J. Immunol. 165:878-87
50. Stahlman MT, Gray ME, Hull WM, Whitsett JA. 2002. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J. Histochem. Cytochem. 50:651-60
51. Madsen J, Kliem A, Tornøe I, Skjødt K, Koch C, Holmskov U. 2000. Localization of lung surfactant protein D (SP-D) on mucosal surfaces in human tissues. J. Immunol. 164:5866-70
52. Rubio S, Lacaze-Masmonteil T, Chailley-Heu B, Kahn A, Bourbon JR, Ducroc R. 1995. Pulmonary suffactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J. Biol. Chem. 270:12162-69
53. Ballard PL. 2000. Scientific rationale for the use of antenatal glucocorticoids to promote fetal development. Pediatr. Rev. 1:E83-90
54. Thiel S, Bjerke T, Hansen D, Poulsen LK, Schiotz PO, Jensenius JC. 1995. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr. Allergy Immunol. 6:20-23
55. Akaiwa M, Yae Y, Sugimoto R, Suzuki SO, Iwaki T, et al. 1999. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J. Histochem. Cytochem. 47:777-86
56. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K. 1999. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94:845-52
57. Teh C, Le Y, Lee SH, Lu J. 2000. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 101:225-32
58. Lu J, Tay PN, Kon OL, Reid KB. 1996. Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. Biochem. J. 313:473-78
59. Pikaar JC, Voorhout WF, van Golde LM, Verhoef J, van Strijp JA, van Iwaarden JF. 1995. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. J. Infect. Dis. 172:481-89
60. Tino MJ, Wright JR. 1996. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 270:L677-88
61. Ikeda K Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-54
62. Kawasaki N, Kawasaki T, Yamashina I. 1989. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J. Biochem. 106:483-89
63. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:688-93
64. Townsend R, Read RC, Turner MW, Klein NJ, Jack DL. 2001. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin. Exp. Immunol. 124:223-28
65. van Emmerik LC, Kuijper EJ, Fijen CA, Dankert J, Thiel S. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97:411-16
66. Polotsky VY, Fischer W, Ezekowitz RA, Joiner KA. 1996. Interactions of human mannose-binding protein with lipoteichoic acids. Infect. Immun. 64:380-83
67. McNeely TB, Coonrod JD. 1994. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am. J. Respir. Cell Mol. Biol. 11:114-22
68. McNeely TB, Coonrod JD. 1993. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J. Infect. Dis. 167:91-97
69. van de Wetering JK, van Eijk M, van Golde LM, Hartung T, van Strijp JA, Batenburg JJ. 2001. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria. J. Infect. Dis. 184:1143-51
70. Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. 2002. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J. Biol. Chem. 277:20379-85
71. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155:5343-51
72. Ferguson JS, Voelker DR, Ulnar JA, Dawson AJ, Schlesinger LS. 2002. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J. Immunol. 168:1309-14
73. McIntosh JC, Swyers AH, Fisher JH, Wright JR. 1996. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 15:509-19
74. Sano H, Sohma H, Muta T, Nomura S, Voelker DR, Kuroki Y. 1999. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163:387-95
75. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR. 2000. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L840-47
76. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. 2000. Surfactant proteins A and D bind CD14 by different mechanisms. J. Biol. Chem. 275:22442-51
77. Chiba H, Sano H, Iwaki D, Murakami S, Mitsuzawa H, et al. 2001. Rat mannose-binding protein a binds CD14. Infect. Immun. 69:1587-92
78. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, et al. 2002. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J. Biol. Chem. 277:6830-37
79. Kremlev SG, Phelps DS. 1994. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am. J. Physiol. Lung Cell Mol. Physiol. 267:L712-19
80. Kremlev SG, Umstead TM, Phelps DS. 1997. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am. J. Physiol. Lung Cell Mol. Physiol. 272:L996-1004
81. Guillot L, Balloy V, McCormack FX, Golenbock DT, Ckignard M, Si-Tahar M. 2002. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:5989-92
82. Crouch E, Hartshorn K, Ofek I. 2000. Collectins and pulmonary innate immunity. Immunol. Rev. 173:52-65
83. Hartshorn KL, Sastry K, White MR, Anders EM, Super M, et al. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91:1414-20
84. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. Lung Cell Mol. Physiol. 273:L1156-66
85. Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E. 1996. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am. J. Physiol. Lung Cell Mol. Physiol. 271:L753-62
86. Benne CA, Kraaijeveld CA, van Strijp JA, Brouwer E, Harmsen M, et al. 1995. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J. Infect. Dis. 171:335-41
87. Reading PC, Hartley CA, Ezekowitz RAB, Anders EM. 1995. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem. Biophys. Res. Commun. 217:1128-36
88. Hartshorn KL, Reid KB, White MR, Jensenius JC, Morris SM, et al. 1996. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87:3450-61
89. Benne CA, Benaissa-Trouw B, van Strijp JA, Kraaijeveld CA, van Iwaarden JF. 1997. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27:886-90
90. Hartley CA, Reading PC, Ward AC, Anders EM. 1997. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 142:75-88
91. Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307-13
92. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169:185-96
93. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ. 1992. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89:143-49
94. O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699-710
95. Schelenz S, Malhotra R, Sim RB, Holmskov U, Bancroft GJ. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360-66
96. Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, et al. 1997. Binding of pulmonary suffactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect. Immun. 65:3171-79
97. Madan T, Kishore U, Singh M, Strong P, Clark H, et al. 2001. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J. Clin. Invest. 107:467-75
98. Green PJ, Feizi T, Stoll MS, Tkiel S, Prescott A, McConville MJ. 1994. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol. Biochem. Parasitol. 66:319-28
99. Kahn SJ, Wleklinski M, Ezekowitz RA, Coder D, Aruffo A, Farr A. 1996. The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein. Infect. Immun. 64:2649-56
100. Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamaskina I. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-54
101. Thiel S. 1992. Mannan-binding protein, a complement activating animal lectin. Immunopharmacology 24:91-99
102. Matsushita M, Ezekowitz RA, Fujita T. 1995. The Gly-54→Asp allelic form of human mannose binding protein (MBP) fails to bind MBP-associated serine protease. Biochem. J. 311:1021-23
103. Kurata H, Cheng HM, Kozutsumi Y, Yokota Y, Kawasaki T. 1993. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin. Biochem. Biophys. Res. Commun. 191:1204-10
104. Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, et al. 1992. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat. Genet. 2:50-55
105. Liu H, Jensen L, Hansen S, Petersen SV, Takahashi K, et al. 2001. Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand. J. Immunol. 53:489-97
106. Law SKA, Reid KBM. 1995. Complement, ed. D Male. Oxford: IRL
107. Carroll MC, Prodeus AP. 1998. Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10:36-40
108. Walker SR, Williams MC, Benson B. 1986. Immunocytochemical localization of the major suffactant apoprotein in type II cells, clare cells, and alveolar macrophages of rat lung. J. Histochem. Cytoehem. 34:1137-48
109. Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, van Golde LM, Geuze HJ. 1992. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J. Histochem. Cytochem. 40:1589-97
110. Crouch EC, Persson A, Griffin GL, Chang D, Senior RM. 1995. Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes. Am. J. Respir. Cell Mol. Biol. 12:410-15
111. van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LM. 1990. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91-98
112. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, Shepherd VL. 1996. Purification of a cell surface receptor for surfactant protein A. J. Biol. Chem. 271:16375-83
113. Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. 1997. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am. J. Physiol. Lung Cell Mol. Physiol. 272:L989-95
114. Holmskov U, Lawson P, Teisner B, Tornoe I, Willis AC, et al. 1997. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J. Biol. Chem. 272:13743-49
115. Prakobphol A, Xu F, Hoang VM, Larsson T, Bergstrom J, et al. 2000. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J. Biol. Chem. 275:39860-66
116. Oho T, Yu H, Yamashita Y, Koga T. 1998. Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans. Infect. Immun. 66:115-21
117. McGreal EP, Ikewaki N, Akatsu H, Morgan BP, Gasque P. 2002. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. J. Immunol. 168:5222-32
118. Coppolino MG, Dedhar S. 1998. Calreticulin. Int. J. Biochem. Cell Biol. 30:553-58
119. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-95
120. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. 2000. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 192:1797-808
121. Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, et al. 1998. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273:28438-43
122. Botas C, Poulain F, Akiyama J, Brown C, Allen L, et al. 1998. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc. Natl. Acad. Sci. USA 95:11869-74
123. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, et al. 2000. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA 97:5972-77
124. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. 1997. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 158:4336-40
125. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. 1998. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 19:700-8
126. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, et al. 2000. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 165:3934-40
127. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. 1999. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 103:1015-121
128. Harrod KS, Trapnell BC, Otake K, Korfhagen TR, Whitsett JA. 1999. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am. J. Physiol. Lung Cell Mol. Physiol. 277:L580-58
129. Li G, Siddiqui J, Hendry M, Akiyama J, Edmondson J, et al. 2002. Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am. J. Respir. Cell Mol. Biol. 26:277-82
130. Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, et al. 2001. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J. Infect. Dis. 183:943-52
131. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. 2001. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167:5868-73
132. Muto S, Sakuma K, Tanigucki A, Matsumoto K. 1999. Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amount of Lewis A and Lewis B antigens. Biol. Pharm. Bull. 22:347-52
133. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. 1999. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein dependent cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 96:371-75
134. Schagat TL, Wofford JA, Wright JR. 2001 Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166:2727-33
135. Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, et al. 2001. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L1453-63
136. Borron P, Veldhuizen RA, Lewis JF, Possmayer F, Caveney A, et al. 1996. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am. J. Respir. Cell Mol. Biol. 5:115-21
137. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. 1998. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J. Immunol. 161:4599-603
138. Mogues T, Ota T, Tauber AI, Sastry KN. 1996. Characterization of two mannose-binding protein cDNAs from rhesus monkey (Macaca mulatta): structure and evolutionary implications. Glycobiology 6:543-50
139. Sekine H, Kenjo A, Azumi K, Ohi G, Takahashi M, et al. 2001. An ancient lectin-dependent complement system in an ascidian: novel lectin isolated from the plasma of the solitary ascidian, Halocynthia roretzi. J. Immunol. 167:4504-10
140. Miller ME, Seals J, Kaye R, Levitsky LC. 1968. A familial, plasma-associated defect of phagocytosis. A new cause of recurrent bacterial infections. Lancet 2:60-63
141. Kerr MA, Falconer JS, Bashey A, Beck JS. 1983. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin. Clin. Exp. Immunol. 54:793-800
142. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2:1236-39
143. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. 1998. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J. Immunol. 161:3169-75
144. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. 1992. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp. Immunol. 90:31-35
145. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods 241:33-42
146. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. 1995. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85:660-67
147. Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, et al. 1992. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat. Genet. 2:50-55
148. Peterslund NA, Koch C, Jensenius JC, Thiel S. 2001. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358:637-38
149. Neth O, Hann I, Turner MW, Klein NJ. 2002. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614-18
150. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C. 1999. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. Br. Med. J. 319:1166-67
151. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, et al. 1999. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104:431-37
152. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. 1994. Dual role of mannan-binding protein in infections: another case of heterosis? Eur. J. Immunogenet. 21:125-31
153. Garred P, Richter C, Andersen AB, Madsen HO, Mtoni I, et al. 1997. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol. 46:204-8
154. Bellamy R, Ruwende, C, McAdam KPWJ, Thursz M, Sumiya M, et al. 1998. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q J M Mon. J. Assoc. Physicians 91:13-18
155. Madsen HO, Videm V, Svejgaard A, Svennevig J-L, Garred P. 1998. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 352:959-60
156. Jordan JE, Montalto MC, Stahl GL. 2002. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104:1413-18
157. Valdimarsson H, Stefansson M, Vikingsdottir T, Arason GJ, Koch C, et al. 1998. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand. J. Immunol. 48:116-23
158. Garred P, Pressler T, Lanng S, Madsen HO, Moser C, et al. 2002. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr. Pulmonol. 33:201-7
159. Vorup-Jensen T, Sorensen ES, Jensen UB, Schwaeble W, Kawasaki T, et al. 2001. Recombinant expression of human mannan-binding lectin. Int. Immunopharmacol. 1:677-87
160. Leth-Larsen R, Nordenbæk C, Møller V, Junker P, Holmskov U. 2003. Serial changes in surfactant protein D in serum from patients with community-acquired pneumonia. Submitted
161. Floros J, Hoover RR. 1998. Genetics of the hydrophilic surfactant proteins A and D. Biochim. Biophys. Acta 408:312-22
162. Crouch E, Rust K, Veile R, Donis-Keller H, Grosso L. 1993. Genomic organization of human surfactant protein D (SP-D). SP-D is encoded on chromosome 10q22.223.1. J. Biol. Chem. 268:2976-83
163. Husby S, Herskind AM, Jensenius JC, Holmskov U. 2002. Heritability estimates for the constitutional levels of the collectins mannan-binding lectin and lung surfactant protein D. A study of unselected like-sexed mono- and dizygotic twins at the age of 6-9 years. Immunology 106:389-94
164. Floros J, Lin HM, Garcia A, Salazar MA, Guo X, et al. 2000. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J. Infect. Dis. 182:1473-78
165. Lahti M, Lofgren J, Marttila R, Rueko M, Klaavuniemi T, et al. 2002. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr. Res. 51:696-99
166. Floros J, Fan R. 2001. Surfactant pro-tein A and B genetic variants and respiratory distress syndrome: allele interactions. Biol. Neonate 80(Suppl. 1):22-25
167. Guo X, Lin HM, Lin Z, Montano M, Sansores R, et al. 2001. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur. Respir. J. 18:482-90
168. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. 2002. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J. Infect. Dis. 185:283-89
169. Hermans C, Bernard A. 1999. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am. J. Respir. Crit. Care Med. 159:646-78
170. Kuroki Y, Takahashi H, Chiba H, Akino T. 1998. Surfactant proteins A and D: disease markers. Biochim. Biophys. Acta 1408:334-45
171. van de Graaf EA, Jansen HM, Lutter R, Alberts C, Kobesen J, et al. 1992. Surfactant protein A in bronchoalveolar lavage fluid. J. Lab. Clin. Med. 120:252-63
172. Malhotra R, Haurum J, Thiel S, Jensenius JC, Sim RB. 1993. Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci. Rep. 13:79-90
173. Wang JY, Kishore U, Lim BL, Strong P, Reid KB. 1996. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin. Exp. Immunol. 106:367-73
174. Madan T, Kishore U, Shah A, Eggleton P, Strong P, et al. 1997. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin. Exp. Immunol. 110:241-49
175. Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, et al. 2000. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am. J. Respir. Crit. Care Med. 162:258-63
176. Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, et al. 2001. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum. 44:1363-69
177. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, et al. 2002. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 165:378-81
178. Greene KE, King TE Jr, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, et al. 2002. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 19:439-46
179. Inaba S, Okochi K, Yae Y, Niklasson F, de Verder CH. 1990. Serological studies of an SLE associated antigen-antibody system discovered as a precipitation reaction in agarose gel: the HAKATA antigen-antibody system. Fukuoka Igaku Zasshi. 81:284-91
180. Fukutomi T, Ando B, Sakamoto S, Sakai H, Nawata H. 1996. Thermolabile beta-2 macroglycoprotein (Hakata antigen) in liver disease: biochemical and immunohistochemical study. Clin. Chim. Acta 255:93-106